Canada — Health Canada
Tracked across 24 events · 315 articles · First seen Feb 13, 2025 · Last active Jun 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Canada — Health Canada granted the Medical Device License to ClearPoint Neuro for its Neuro Navigation System, facilitating its use in Canadian neurosurgery centers.
Apr 20, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada issued a recall notice for the above-ground pools sold in Canada, aligning with the United States — United States Consumer Product Safety Commission's actions.
Jul 21, 2025 · 24 articles
Business
Impact: Canada — Health Canada published notices regarding the Peloton Interactive recall, affecting units sold in Canada and advising owners to seek a free seat post replacement.
Nov 06, 2025 · 14 articles
Business
Emerging Growth Research released a flash report on Diagnosis, a publicly traded Canadian corporation specializing in AI-powered early detection of eye-related health problems. The report highlights Diagnosis's progress towards key regulatory approvals with Canada —…
Impact: Diagnosis is pursuing regulatory clearance with Canada — Health Canada>>> for its CARA platform, a key milestone for market expansion in Canada.
Jun 05, 2026 · 11 articles
Business
Optimi Health, a pharmaceutical manufacturer, has announced it secured naturally derived ibogaine and will begin developing finished drug products this summer at its GMP facility in British Columbia, Canada. This initiative follows a U.S. Executive…
Impact: Canada — Health Canada's regulation of ibogaine under the Food and Drugs Act and its listing on the Prescription Drug List provides a favorable regulatory environment for Optimi Health's operations.
Jun 08, 2026 · 14 articles
Business
ExCellThera Inc. and its subsidiary Cordex Biologics have announced exclusive licensing and supply agreements with Medexus Pharmaceuticals, granting Medexus Pharmaceuticals the Canadian commercialization rights for Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel (UM171 Cell Therapy). Allogeneic…
Impact: Canada — Health Canada is the regulatory body whose approval is required for Medexus Pharmaceuticals to begin commercializing Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel in Canada.
Jun 10, 2026 · 6 articles
Tech
Researchers have reported a significant breakthrough in treating advanced pancreatic cancer with an experimental pill called daraxonrasib, developed by Revolution Medicines. The daily pill nearly doubled the median survival time for patients whose metastatic cancer…
Impact: Canada — Health Canada>>> has not yet received an application to license daraxonrasib in Canada>>>. Its role is to regulate and approve new drugs for use in the country, impacting the timeline for Canadian patient access.
May 29, 2026 · 74 articles
Regulatory
Impact: Canada — Health Canada issued a corresponding notice for the recall of Ryobi pressure washers in Canada, ensuring consumer safety in the region.
Aug 28, 2025 · 7 articles
Regulatory
Impact: Canada — Health Canada is the regulatory body in Canada to which Diagnosis plans to submit CARA for approval, impacting its commercialization in Canada.
Apr 08, 2026 · 6 articles
Accidents
A 3-year-old girl died from injuries after an inflatable castle was tossed into the air by strong winds during a community celebration at Parc Ouellet in LaSalle, a borough of Canada — Montreal, on May…
Impact: Canada — Health Canada advises on safety guidelines for inflatable structures, and its recommendations are highlighted in the context of this accident.
Jun 02, 2026 · 6 articles
Business
Optimi Health, a pharmaceutical manufacturer of regulated psychedelic drug products, has completed its first export of naturally derived psilocybin, including biomass and 5mg capsules, to the United Kingdom. This shipment will support a planned Phase…
Impact: Canada — Health Canada issued the Drug Establishment Licence (DEL) to Optimi Health, authorizing the company's manufacturing, packaging, labeling, testing, storage, and distribution of controlled drug products.
Jun 02, 2026 · 25 articles
Business
Lophos Holdings Inc. provided a corporate update on June 11, 2026, detailing significant changes and challenges. Josh Herman was appointed CEO, and Cotton and Cory Harris joined the Board of Directors, with Evan Stawnyczy stepping…
Impact: Canada — Health Canada is the issuer of the Controlled Substances Dealer's Licence that Lophos Pharmaceuticals Corporation previously held, impacting the company's ability to conduct controlled substance activities.
Jun 12, 2026 · 6 articles
Business
Impact: Canada — Health Canada regulations are a key area of Dell Technologies's expertise, which Registrar Corp will now offer to its clients.
Apr 16, 2026 · 6 articles
Regulatory
Impact: Canada — Health Canada pushed back against Donald Trump's claims, reminding Canadians that Tylenol is a recommended treatment for fever and pain during pregnancy.
Oct 28, 2025 · 20 articles
Tech
Arrowhead Pharmaceuticals presented new positive clinical data for Plozasiran at the 94th European Atherosclerosis Society Congress. The data support the use of Plozasiran in patients with moderate-to-severe renal impairment or moderate hepatic impairment without dose…
Impact: Canada — Health Canada previously approved REDEMPLO (plozasiran), contributing to its international market presence.
May 26, 2026 · 6 articles
Business
Impact: Canada — Health Canada had licensed MyndTec's MyndMove system, indicating its prior regulatory approval.
Apr 08, 2026 · 6 articles
80
Medexus Pharmaceuticals intends seek approval Canada — Health CanadaMedexus licenses Zemcelpro...
60
Canada — Health Canada advised operatorsMontreal bouncy castle...
60
Canada — Health Canada issued export authorization Optimi HealthOptimi Health exports...
NEWSDESK
Track Canada — Health Canada live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard